JP2012532901A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532901A5
JP2012532901A5 JP2012519902A JP2012519902A JP2012532901A5 JP 2012532901 A5 JP2012532901 A5 JP 2012532901A5 JP 2012519902 A JP2012519902 A JP 2012519902A JP 2012519902 A JP2012519902 A JP 2012519902A JP 2012532901 A5 JP2012532901 A5 JP 2012532901A5
Authority
JP
Japan
Prior art keywords
het
atoms
nha
proportions
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012519902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532901A (ja
Filing date
Publication date
Priority claimed from DE102009033392A external-priority patent/DE102009033392A1/de
Application filed filed Critical
Publication of JP2012532901A publication Critical patent/JP2012532901A/ja
Publication of JP2012532901A5 publication Critical patent/JP2012532901A5/ja
Pending legal-status Critical Current

Links

JP2012519902A 2009-07-16 2010-06-17 オートタキシン阻害剤としての複素環式化合物 Pending JP2012532901A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102009033392A DE102009033392A1 (de) 2009-07-16 2009-07-16 Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
DE102009033392.4 2009-07-16
PCT/EP2010/003661 WO2011006569A1 (de) 2009-07-16 2010-06-17 Heterocyclische verbindungen als autotaxin-inhibitoren

Publications (2)

Publication Number Publication Date
JP2012532901A JP2012532901A (ja) 2012-12-20
JP2012532901A5 true JP2012532901A5 (en:Method) 2013-08-08

Family

ID=42646326

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519902A Pending JP2012532901A (ja) 2009-07-16 2010-06-17 オートタキシン阻害剤としての複素環式化合物

Country Status (16)

Country Link
US (1) US20120115852A1 (en:Method)
EP (1) EP2454258A1 (en:Method)
JP (1) JP2012532901A (en:Method)
KR (1) KR20120090031A (en:Method)
CN (1) CN102471343A (en:Method)
AR (1) AR077488A1 (en:Method)
AU (1) AU2010272922A1 (en:Method)
BR (1) BR112012000792A2 (en:Method)
CA (1) CA2768095A1 (en:Method)
DE (1) DE102009033392A1 (en:Method)
EA (1) EA201200119A1 (en:Method)
IL (1) IL217466A0 (en:Method)
MX (1) MX2012000609A (en:Method)
SG (1) SG177522A1 (en:Method)
WO (1) WO2011006569A1 (en:Method)
ZA (1) ZA201201124B (en:Method)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014030473A2 (pt) 2012-06-13 2017-06-27 Hoffmann La Roche novo diazaespirocicloalcano e azaespirocicloalcano
SI2900669T1 (sl) * 2012-09-25 2019-12-31 F. Hoffmann-La Roche Ag Derivati heksahidropirolo(3,4-C)pirola in sorodne spojine kot zaviralci avtotaksina (ATX) in kot zaviralci tvorbe lizofosfatidne kisline (LPA) za zdravljenje npr. bolezni ledvic
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
CA2895448A1 (en) 2012-12-19 2014-06-26 Novartis Ag Autotaxin inhibitors
AR095079A1 (es) * 2013-03-12 2015-09-16 Hoffmann La Roche Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
TW201446768A (zh) * 2013-03-15 2014-12-16 Biogen Idec Inc S1p及/或atx調節劑
WO2015042053A1 (en) 2013-09-17 2015-03-26 Pharmakea, Inc. Vinyl autotaxin inhibitor compounds
WO2015042052A1 (en) 2013-09-17 2015-03-26 Pharmakea, Inc. Heterocyclic vinyl autotaxin inhibitor compounds
WO2015048301A1 (en) 2013-09-26 2015-04-02 Pharmakea, Inc. Autotaxin inhibitor compounds
WO2015077503A1 (en) 2013-11-22 2015-05-28 Pharmakea, Inc. Autotaxin inhibitor compounds
MX2016006688A (es) 2013-11-22 2016-11-29 Pharmakea Inc Inhibidores tetraciclicos de autotaxina.
JP6496730B2 (ja) 2013-11-26 2019-04-03 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規なオクタヒドロ−シクロブタ[1,2−c;3,4−c’]ジピロール−2−イル
MX373236B (es) * 2014-03-26 2020-05-08 Hoffmann La Roche Compuestos condensados de [1,4]diazepina como inhibidores de producción de la autotaxina (atx) y ácido lisofosfatidico (lpa).
MX370659B (es) 2014-03-26 2019-12-19 Hoffmann La Roche Compuestos bicíclicos como inhibidores de producción de autotaxina (atx) y ácido lisofosfatídico (lpa).
AU2015240519B2 (en) 2014-04-04 2019-08-15 X-Rx, Inc. Substituted spirocyclic inhibitors of autotaxin
EP3134079A4 (en) * 2014-04-23 2017-12-20 X-RX Discovery, Inc. Substituted n-(2-(amino)-2-oxoethyl)benzamide inhibitors of autotaxin and their preparation and use in the treatment of lpa-dependent or lpa-mediated diseases
US9051320B1 (en) 2014-08-18 2015-06-09 Pharmakea, Inc. Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
GB201501870D0 (en) 2015-02-04 2015-03-18 Cancer Rec Tech Ltd Autotaxin inhibitors
GB201502020D0 (en) 2015-02-06 2015-03-25 Cancer Rec Tech Ltd Autotaxin inhibitory compounds
MA41898A (fr) 2015-04-10 2018-02-13 Hoffmann La Roche Dérivés de quinazolinone bicyclique
IL280863B2 (en) 2015-05-27 2024-07-01 Sabre Therapeutics Llc Autotaxin inhibitors and uses thereof
EP3302465A1 (en) 2015-06-05 2018-04-11 Vertex Pharmaceuticals Incorporated Triazoles for the treatment of demyelinating diseases
GB201510010D0 (en) 2015-06-09 2015-07-22 King S College London PDD and BPD compounds
GB201514928D0 (en) 2015-08-21 2015-10-07 King S College London PDD compounds
US20180339985A1 (en) 2015-08-21 2018-11-29 Femtogenix Limited Pdd compounds
MX387736B (es) 2015-09-04 2025-03-18 Hoffmann La Roche Derivados de fenoximetilo.
PE20180461A1 (es) 2015-09-24 2018-03-06 Hoffmann La Roche Nuevos compuestos biciclicos como inhibidores de la atx
KR20180054634A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 이중 오토탁신(atx)/탄산 무수화효소(ca) 억제제로서 신규한 이환형 화합물
CA2984585A1 (en) 2015-09-24 2017-03-30 F. Hoffmann-La Roche Ag New bicyclic compounds as dual atx/ca inhibitors
KR20180054635A (ko) 2015-09-24 2018-05-24 에프. 호프만-라 로슈 아게 오토탁신(atx) 억제제로서 이환형 화합물
WO2018106643A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Heterocyclic azoles for the treatment of demyelinating diseases
WO2018106641A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Pyrazoles for the treatment of demyelinating diseases
WO2018106646A1 (en) 2016-12-06 2018-06-14 Vertex Pharmaceuticals Incorporated Aminotriazoles for the treatment of demyelinating diseases
CN110392679B (zh) 2017-03-16 2023-04-07 豪夫迈·罗氏有限公司 可用作双重atx/ca抑制剂的杂环化合物
WO2018167113A1 (en) 2017-03-16 2018-09-20 F. Hoffmann-La Roche Ag New bicyclic compounds as atx inhibitors
JP6687816B1 (ja) * 2018-05-21 2020-04-28 株式会社アシックス ブラジャー
KR102623218B1 (ko) * 2018-08-23 2024-01-11 가천대학교 산학협력단 페닐아세트산 유도체 및 이를 유효성분으로 함유하는 자가면역질환 예방 또는 치료용 조성물
US12048678B2 (en) * 2018-10-02 2024-07-30 Case Western Reserve University Compounds for treating myelin related disorders
US20250134907A1 (en) * 2022-02-10 2025-05-01 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Fused diazepines as agonists of the insulin-like 3 (insl3) peptide receptor rxfp2 and methods of use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
ME00129B (me) * 1999-01-19 2010-10-10 Ortho Mcneil Janssen Pharmaceuticals Inc Triciklicnj benzodiazepini kao antagonisti receptora vazopresina
GB9904387D0 (en) 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
EP1187633A4 (en) 1999-04-08 2005-05-11 Arch Dev Corp USE OF ANTI-VEGF ANTIBODIES TO ENHANCE RADIATION IN ANTICANCER THERAPY
AU1400401A (en) * 1999-11-09 2001-06-06 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment

Similar Documents

Publication Publication Date Title
JP2012532901A5 (en:Method)
JP2011530545A5 (en:Method)
JP2010532768A5 (en:Method)
JP2012506389A5 (en:Method)
JP2015529229A5 (en:Method)
AR077488A1 (es) Compuestos heterociclicos nitrogenados inhibidores de autotaxina, medicamentos que los contienen y uso de los mismos para el tratamiento y/o prevencion de cancer y enfermedades tumorales.
HRP20220886T1 (hr) Pripravci i postupci za proizvodnju pirimidina i spojeva piridina s btk inhibicijskom aktivnošću
HRP20201681T1 (hr) Inhibitor aurora a kinaze
JP2018510191A5 (en:Method)
RU2016147727A (ru) Гетероциклилбутанамидные производные
JP2010532774A5 (en:Method)
JP2012532899A5 (en:Method)
CN113784970A (zh) Erk抑制剂及其应用
JP2015524450A5 (en:Method)
JP2018516963A5 (en:Method)
JP2011510028A5 (en:Method)
JP2014508811A5 (en:Method)
RU2018116351A (ru) Пиримидиновое соединение
JP2016503799A5 (en:Method)
JP2014518884A5 (en:Method)
EA032971B1 (ru) Соль берберина и урсодезоксихолевой кислоты и ее применение
RU2018106914A (ru) 1,3,4,-оксадизоламидное производное соединение в качестве ингибитора гистондеацетилазы 6 и содержащая его фармацевтическая композиция
JP2017141277A5 (en:Method)
RU2015115278A (ru) Производные гидропирролопиррола для применения в качестве ингибиторов синтазы жирных кислот
WO2014174524A8 (en) A novel composition for nonalcoholic fatty liver disease (nafld)